Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 3-[N-(4-methoxyphenyl)-N-methylamino]propionate is a complex organic compound with the chemical formula C12H18NO3. It is a derivative of amino acids, featuring a methyl group attached to the nitrogen atom of an amino group, and a 4-methoxyphenyl group connected to the nitrogen as well. methyl 3-[N-(4-methoxyphenyl)-N-methylamino]propionate is known for its potential applications in pharmaceuticals, particularly as a precursor in the synthesis of certain drugs. Its structure and properties make it a versatile building block in the creation of various medicinal compounds, highlighting its importance in the field of organic chemistry and drug development.

2003-71-6

Post Buying Request

2003-71-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2003-71-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2003-71-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,0 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2003-71:
(6*2)+(5*0)+(4*0)+(3*3)+(2*7)+(1*1)=36
36 % 10 = 6
So 2003-71-6 is a valid CAS Registry Number.

2003-71-6Relevant academic research and scientific papers

Synthesis and quantitative structure-activity relationship of imidazotetrazine prodrugs with activity independent of O6-methylguanine-DNA- methyltransferase, DNA mismatch repair, and p53

Pletsas, Dimitrios,Garelnabi, Elrashied A.E.,Li, Li,Phillips, Roger M.,Wheelhouse, Richard T.

, p. 7120 - 7132 (2013/10/01)

The antitumor prodrug temozolomide is compromised by its dependence for activity on DNA mismatch repair (MMR) and the repair of the chemosensitive DNA lesion, O6-methylguanine (O6-MeG), by O6-methylguanine-DNA-methyltransferase (E.C. 2.1.1.63, MGMT). Tumor response is also dependent on wild-type p53. Novel 3-(2-anilinoethyl)-substituted imidazotetrazines are reported that have activity independent of MGMT, MMR, and p53. This is achieved through a switch of mechanism so that bioactivity derives from imidazotetrazine-generated arylaziridinium ions that principally modify guanine-N7 sites on DNA. Mono- and bifunctional analogues are reported, and a quantitative structure-activity relationship (QSAR) study identified the p-tolyl-substituted bifunctional congener as optimized for potency, MGMT-independence, and MMR-independence. NCI60 data show the tumor cell response is distinct from other imidazotetrazines and DNA-guanine-N7 active agents such as nitrogen mustards and cisplatin. The new imidazotetrazine compounds are promising agents for further development, and their improved in vitro activity validates the principles on which they were designed.

Palladium-catalyzed intramolecular nucleophilic substitution at the alkoxycarbonyl group

Sole, Daniel,Serrano, Olga

, p. 7270 - 7272 (2008/09/17)

(Chemical Equation Presented) Coaxed into action: Although ester groups are usually inert towards organopalladium reagents, β-(2-haloanilino)esters undergo intramolecular palladium-catalyzed acylation to give dihydroquinolin-4-ones (see scheme). A four-me

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2003-71-6